Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Biography

With a background in molecular biology and medicine, Prof Henrik Zetterberg has spent the past 15 years focusing on the development of biomarkers for Alzheimer’s disease and other brain disorders - becoming a world expert in the process. He has published more than 1100 scientific articles and has received numerous awards.

News

Key publications

Brain pathology (Zurich, Switzerland)
Published

Dysregulated TIE-2 expression is associated with blood-brain barrier leakiness and Alzheimer's disease-related neuropathology

Authors
Selvi Ince, Carol Van Hulle, Gwendlyn Kollmorgen, Clara Quijano-Rubio, Carey Gleason, Barbara B Bendlin, Ozioma Okonkwo, Sanjay Asthana, Kaj Blennow, Henrik Zetterberg, Sterling C Johnson, Seth Love, J Scott Miners
Dysregulated TIE-2 expression is associated with blood-brain barrier leakiness and Alzheimer's disease-related neuropathology
Molecular neurodegeneration
Published

Tau extent outperforms tau load as a predictor of neurodegeneration in Alzheimer's disease

Authors
Arthur C Macedo, Lydia Trudel, Seyyed Ali Hosseini, Joseph Therriault, Étienne Aumont, Gleb Bezgin, Nesrine Rahmouni, Jenna Stevenson, Cécile Tissot, Marcel S Woo, Stijn Servaes, Stuart Mitchell, Jaime Fernandez-Arias, Brandon Hall, Tevy Chan, Marina Pereira Gonçalves, Pamela C L Ferreira, João Pedro Ferrari-Souza, Bruna Bellaver, Firoza Z Lussier, Andréa L Benedet, Nicholas J Ashton, Henrik Zetterberg, Kaj Blennow, Dana L Tudorascu, Eduardo R Zimmer, Maxime Montembeault, Jean-Paul Soucy, Jesse Klostranec, Tharick A Pascoal, Paolo Vitali, Pedro Rosa-Neto
Tau extent outperforms tau load as a predictor of neurodegeneration in Alzheimer's disease

Zetterberg Lab

Explore the work of the Zetterberg Lab, pioneering the development of fluid biomarkers for dementia

Zetterberg Lab